Reductive Alkylation Catalyst for Naltrexone Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing naltrexone and structurally similar compounds face challenges such as low yields, use of hazardous metal hydride reagents, and the need for high temperatures and prolonged reaction times, which limit efficiency and safety in large-scale production.

Innovation Solution

A process involving the reaction of specific compounds with a reductive alkylation catalyst in the presence of hydrogen, avoiding hazardous reagents and extreme conditions, to produce naltrexone and similar compounds with improved yields and safety.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If metal hydride reagents are used to reduce the condensation product, then the reduction reaction can proceed, but hazardous safety issues and low yields (approximately 33%) occur

Engineering Contradiction:
ImprovesafetyVSAvoidyield
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent removes the hazardous metal hydride reagent from the reaction system and replaces it with a catalytic hydrogenation system using hydrogen gas and a metal catalyst. This extraction of the dangerous substance eliminates safety hazards while maintaining or improving reaction efficiency through catalytic pathways.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the chemical reduction mechanism using metal hydrides with a catalytic hydrogenation mechanism using hydrogen gas and metal catalysts. This substitution transforms the reaction pathway from a stoichiometric chemical reduction to a catalytic process that is both safer and more efficient.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If protection and deprotection steps are incorporated to prevent side reactions, then the ketone functional group is protected, but the process complexity and number of steps increase

Engineering Contradiction:
ImproveselectivityVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent removes the protection and deprotection steps from the synthetic pathway by using a catalyst that selectively hydrogenates the imine bond while leaving the ketone functional group unaffected. This extraction of unnecessary steps simplifies the overall process while maintaining high selectivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the reaction parameters by using specific catalysts and controlling hydrogenation conditions to achieve selective reduction. By adjusting catalyst type, hydrogen pressure, and temperature, the reaction selectively targets the imine bond without affecting the ketone group, eliminating the need for protection steps.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If direct coupling of cyclopropylmethylbromide and noroxymorphone is performed in dimethylformamide, then the reaction can proceed, but high temperatures (70°C) and prolonged reaction times (7 days) are required with only 60% theoretical yield

Engineering Contradiction:
ImproveyieldVSAvoidreaction time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent performs preliminary formation of the imine condensation product between noroxymorphone and cyclopropylcarbonyl chloride, which then undergoes catalytic hydrogenation. This preliminary step creates a reactive intermediate that can be efficiently reduced under milder conditions, avoiding the need for high temperatures and prolonged reaction times required in direct coupling methods.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces a catalytic hydrogenation system as an intermediary step between condensation and final product formation. The catalyst mediates the reduction of the imine bond, enabling the reaction to proceed under milder conditions with higher efficiency compared to direct thermal coupling methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Productivity

If high temperatures and prolonged reaction times are used for direct coupling, then the reaction can proceed to completion, but energy consumption increases and production efficiency decreases

Engineering Contradiction:
Improvereaction efficiencyVSAvoidenergy consumption
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The patent replaces thermal energy input with catalytic action. Instead of relying on high temperatures to drive the reaction, a metal catalyst facilitates the hydrogenation process under milder conditions, significantly reducing energy consumption while improving reaction efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the reaction parameters by using catalytic hydrogenation conditions (moderate temperature, hydrogen pressure) instead of high-temperature thermal coupling. This parameter change enables the reaction to proceed efficiently with much lower energy input and shorter reaction times.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves higher yields and eliminates the need for hazardous reagents and high temperatures, enhancing the efficiency and safety of producing naltrexone and related compounds.

Implementation Method 1

a compound of formula (D), (E) or (F) is reacted with a compound of formula (G) in the presence of hydrogen and a reductive alkylation catalyst

Methodology Applied
Scientific EffectReductive alkylation: Reduction

Implementation Method 2

in the presence of hydrogen and a reductive alkylation catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS8119803B2Preparation of opiate analgesics by reductive alkylation
Publication Date: 2012.02.21 MACFARLAN SMITH
  • US8119803B2 patent drawing
  • US8119803B2 patent drawing
  • US8119803B2 patent drawing

AI summary

A process for preparing a compound of formula (A), (B) or (C):wherein P is H, CH3 or a hydroxyl protecting group; X is O, a protected ketone, OH, a protected hydroxyl group or H; Y is OH, a protected hydroxyl group or H; W is C(CH3)2OH, (CH3)(C(CH3)3)OH or COCH3; Z is C2-C10 alkyl or C2-C10 arylalkyl; and is a single bond or a double bond, is disclosed. The process includes reductive alkylation in the presence of hydrogen and a reductive alkylation catalyst.